Study to Evaluate Efficacy and Safety of LIB003 in Patients on Lipid-Lowering Therapy Needing Additional LDL-C Reduction

NCT03549260 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

81

Enrollment

INDUSTRY

Sponsor class

Conditions

LDL Cholesterol

Interventions

BIOLOGICAL: LIB003

Sponsor

LIB Therapeutics LLC

Collaborators

[object Object]